{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T07:06:11Z","timestamp":1775718371307,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1124\/dmd.32.2.267","type":"journal-article","created":{"date-parts":[[2004,1,26]],"date-time":"2004-01-26T20:25:10Z","timestamp":1075148710000},"page":"267-271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":147,"title":["IDENTIFICATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASE ENZYME(S) RESPONSIBLE FOR THE GLUCURONIDATION OF POSACONAZOLE (NOXAFIL)"],"prefix":"10.1016","volume":"32","author":[{"given":"Anima","family":"Ghosal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Hapangama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Achanfuo-Yeboah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Iannucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swapan","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Alton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James E.","family":"Patrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shmuel","family":"Zbaida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.32.2.267_bib1","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/jac\/48.6.769","article-title":"Activity of the new antifungal triazole, posaconazole, against Cryptococcus neoformans.","volume":"48","author":"Barchiesi","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1124\/dmd.32.2.267_bib2","unstructured":"Dehal SS, Gagne PV, Crespi CL, and Patten CJ (2001) Characterization of a probe substrate and an inhibitor of UDP glucuronosyltransferase (UGT) 1A4 activity in human liver microsomes (HLM) and cDNA-expressed UGT-enzymes. Abstract 321, in 6th International ISSX Meeting, Munich, Germany, p. 162."},{"key":"10.1124\/dmd.32.2.267_bib3","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0090-9556(24)15100-8","article-title":"In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin.","volume":"28","author":"Fisher","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.32.2.267_bib4","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1124\/dmd.30.9.991","article-title":"N-glucuronidation of nicotine and cotinine in human: formation of cotinine glucuronide in liver microsomes and lack of catalysis by 10 examined UDP-glucuronosyltransferases.","volume":"30","author":"Ghosheh","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.32.2.267_bib5","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1128\/AAC.46.5.1352-1356.2002","article-title":"In vitro and in vivo activities of posaconazole against Coccidioides immitis.","volume":"46","author":"Gonzalez","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/dmd.32.2.267_bib6","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0090-9556(24)15257-9","article-title":"Retigabine N-glucuronidation and its potential role in enterohepatic circulation.","volume":"27","author":"Hiller","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.32.2.267_bib7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/hup.403","article-title":"Glucuronidation of olanzapine by cDNA-expressed human UDP glucuronosyl-transferases and human liver microsomes","volume":"17","author":"Linnet","year":"2002","journal-title":"Hum Psychopharmacol"},{"key":"10.1124\/dmd.32.2.267_bib8","unstructured":"Pfaller, MA, Messer SA, Hollis RJ, Jones RN, and The SENTRY Participants Group (2001) Antifungal activity of posaconazole, ravuconazole and voriconazole compared to that of itraconazole tested against 213 clinical isolates of Aspergillus spp. and other filamentous fungi: report from the SENTRY Antimicrobial Surveillance Program, 2000. Presented at Interscience Conference on Antimicrobial Agents and Chemotherapy, December 16-19, 2001, Chicago, IL, p 379."},{"key":"10.1124\/dmd.32.2.267_bib9","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0090-9556(24)15254-3","article-title":"Characterization of the UDP-glucuronosyltransferases involved in the glucuronidation of an antithrombotic thioxyloside in rat and humans.","volume":"27","author":"Pless","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.32.2.267_bib10","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1146\/annurev.pharmtox.40.1.581","article-title":"Human UDP-glucuronosyltransferases: metabolism, ex-pression and disease.","volume":"40","author":"Tukey","year":"2000","journal-title":"Annu Rev Pharmacol Toxicol"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624028629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624028629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.32.2.267","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:49:55Z","timestamp":1739897395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624028629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S0090955624028629"],"URL":"https:\/\/doi.org\/10.1124\/dmd.32.2.267","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IDENTIFICATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASE ENZYME(S) RESPONSIBLE FOR THE GLUCURONIDATION OF POSACONAZOLE (NOXAFIL)","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.32.2.267","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2004 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}